Search research articles
Contact Us
Filters
Showing results (31-40 of 109) with videos related to
Page
of 11
Sort By:
Frontiers in Psychiatry
|
October 26, 2019
Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
Renrong Wu, Yangpan Ou, Feng Liu, et al.
Ebiomedicine
|
July 17, 2019
Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples
Huabing Li, Wenbin Guo, Feng Liu, et al.
Psychiatry Research
|
August 4, 2014
Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia
Jianhua Sheng, Chunbo Li, Jijun Wang, et al.
Journal of Clinical Psychopharmacology
|
February 10, 2018
No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia
Fang Liu, Liqin Xie, Bingkui Zhang, et al.
Psychiatry Research
|
May 8, 2022
The effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-naïve, first episode schizophrenia patients
Xue Li, Xiuxia Yuan, Lijuan Pang, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Triglyceride/high-density lipoprotein cholesterol ratio: a surrogate to predict insulin resistance and low-density lipoprotein cholesterol particle size in nondiabetic patients with schizophrenia
Xiaoduo Fan, Emily Y Liu, Vicki Poole Hoffman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 10, 2017
Gray matter volume showed dynamic alterations in methamphetamine users at 6 and 12months abstinence: A longitudinal voxel-based morphometry study
Xiaolu Ruan, Na Zhong, Zhi Yang, et al.
Psychopharmacology
|
February 13, 2019
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial
Xiaoduo Fan, Paul Copeland, Shukair Nawras, et al.
Frontiers in Psychiatry
|
September 9, 2021
The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
Xue Li, Xiaoduo Fan, Xiuxia Yuan, et al.
Journal of Clinical Psychopharmacology
|
August 27, 2011
Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia
Christina P C Borba, Xiaoduo Fan, Paul M Copeland, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 109) with videos related to
Sort By:
Page
of 11
Frontiers in Psychiatry
|
October 26, 2019
Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
Renrong Wu, Yangpan Ou, Feng Liu, et al.
Ebiomedicine
|
July 17, 2019
Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples
Huabing Li, Wenbin Guo, Feng Liu, et al.
Psychiatry Research
|
August 4, 2014
Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia
Jianhua Sheng, Chunbo Li, Jijun Wang, et al.
Journal of Clinical Psychopharmacology
|
February 10, 2018
No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia
Fang Liu, Liqin Xie, Bingkui Zhang, et al.
Psychiatry Research
|
May 8, 2022
The effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-naïve, first episode schizophrenia patients
Xue Li, Xiuxia Yuan, Lijuan Pang, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Triglyceride/high-density lipoprotein cholesterol ratio: a surrogate to predict insulin resistance and low-density lipoprotein cholesterol particle size in nondiabetic patients with schizophrenia
Xiaoduo Fan, Emily Y Liu, Vicki Poole Hoffman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 10, 2017
Gray matter volume showed dynamic alterations in methamphetamine users at 6 and 12months abstinence: A longitudinal voxel-based morphometry study
Xiaolu Ruan, Na Zhong, Zhi Yang, et al.
Psychopharmacology
|
February 13, 2019
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial
Xiaoduo Fan, Paul Copeland, Shukair Nawras, et al.
Frontiers in Psychiatry
|
September 9, 2021
The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
Xue Li, Xiaoduo Fan, Xiuxia Yuan, et al.
Journal of Clinical Psychopharmacology
|
August 27, 2011
Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia
Christina P C Borba, Xiaoduo Fan, Paul M Copeland, et al.
Page
of 11